Literature DB >> 9342769

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

W E Müller1, M Rolli, C Schäfer, U Hafner.   

Abstract

Since the mechanism of the antidepressant activity of hypericum extract is not yet understood, we tested possible effects of standardized hypericum extract (LI 160) in several biochemical models relevant for the mechanism of action of other antidepressant drugs. While LI 160 was only a weak inhibitor of MAO-A and MAO-B activity, it inhibited the synaptosomal uptake of serotonin, dopamine and norepinephrine with about equal affinity-2 micrograms/ml). Moreover, subchronic treatment of rats with hypericum extract led to a significant down-regulation of beta-receptors and to a significant up-regulation of 5-HT2-receptors in the frontal cortex. The data might suggest that hypericum extract acts via similar biochemical mechanisms to other antidepressants (e.g. tricyclics).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342769     DOI: 10.1055/s-2007-979528

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  28 in total

1.  Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatment.

Authors:  Feng Chen; Amir H Rezvani; Andrew J Lawrence
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

Review 2.  St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

Authors:  L Henderson; Q Y Yue; C Bergquist; B Gerden; P Arlett
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

3.  Herbal medications for common ailments in the elderly.

Authors:  E Ernst
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 4.  St John's wort: a potential therapy for elderly depressed patients?

Authors:  E U Vorbach; K H Arnoldt; E Wolpert
Journal:  Drugs Aging       Date:  2000-03       Impact factor: 3.923

Review 5.  Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.

Authors:  Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  St. John's Wort enhances the synaptic activity of the nucleus of the solitary tract.

Authors:  Katie M Vance; David M Ribnicky; Gerlinda E Hermann; Richard C Rogers
Journal:  Nutrition       Date:  2014-02-28       Impact factor: 4.008

7.  Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex.

Authors:  Takashi Yoshitake; Ryuji Iizuka; Shimako Yoshitake; Pia Weikop; Walter E Müller; Sven Ove Ogren; Jan Kehr
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 8.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.

Authors:  Wendy Weber; Ann Vander Stoep; Rachelle L McCarty; Noel S Weiss; Joseph Biederman; Jon McClellan
Journal:  JAMA       Date:  2008-06-11       Impact factor: 56.272

Review 10.  Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines.

Authors:  Thomas K H Chang
Journal:  AAPS J       Date:  2009-08-18       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.